Cocrystal Pharma, Inc.
SEC CIK 1412486 · COCP · last insider filing 2026-06-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Frost Phillip MD ET AL | Director | filed 2014 - 2026 |
| Hassan Fred | Director | filed 2023 - 2026 |
| Pfenniger Richard C JR | Director | filed 2021 - 2026 |
| Rubin Steven D | Director | filed 2014 - 2026 |
| Kornberg Roger D. | Director | filed 2014 - 2026 |
| Lee Sam | Director · President and Co-Interim CEO | filed 2014 - 2026 |
| Japour Anthony J | Director | filed 2019 - 2026 |
| Schinazi Raymond F | Director | filed 2014 - 2021 |
| Wilcox Gary | Director · Interim CEO | filed 2014 - 2020 |
| Brady Todd R. | Director | filed 2019 - 2019 |
| Hsiao Jane PH D | Director | filed 2014 - 2018 |
| Block David S | Director | filed 2014 - 2018 |
| Meckler Jeffrey A | Director · CHIEF EXECUTIVE OFFICER | filed 2014 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Sapirstein James | Chief Executive Officer | filed 2026 - 2026 |
| Martin James Joseph | Interim CFO | filed 2017 - 2026 |
| Dale Curtis | INTERIM CFO | filed 2015 - 2015 |
| Mayers Douglas L | CHIEF MEDICAL OFFICER | filed 2015 - 2015 |
| Linscott Walt Addison | GENERAL COUNSEL AND SECRETARY | filed 2015 - 2015 |
| Mcguire Gerald A | Chief Financial Officer | filed 2014 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.